Structural variants involving MLLT10 fusion are associated with adverse outcomes in pediatric acute myeloid leukemia.
Abla O, Ries RE, Triche T Jr, Gerbing RB, Hirsch B, Raimondi S, Cooper T, Farrar JE, Buteyn N, Harmon LM, Wen H, Deshpande AJ, Kolb EA, Gamis AS, Aplenc R, Alonzo T, Meshinchi S.
Abla O, et al. Among authors: wen h.
Blood Adv. 2024 Apr 23;8(8):2005-2017. doi: 10.1182/bloodadvances.2023010805.
Blood Adv. 2024.
PMID: 38306602
Free PMC article.